Leslie Spry, MD
Nephrology · Lincoln, NENPI 1679522528
Payments from drug & device makers
Across 405 payments — averaging $1906.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Akebia Therapeutics Inc$210K
- Vertex$165K
- CSL Behring$160K
- Bayer$87K
- Astrazeneca UK Limited$56K
- Merck$33K
- plus $61K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Akebia Therapeutics Inc | 191 | $209,737 |
| Vertex | 1 | $165,281 |
| CSL Behring | 60 | $159,789 |
| Bayer | 67 | $87,433 |
| Astrazeneca UK Limited | 6 | $55,647 |
| Merck | 2 | $33,495 |
| Alnylam Pharmaceuticals Inc. | 12 | $26,550 |
| AstraZeneca | 6 | $18,126 |
| Travere Therapeutics, Inc. | 7 | $7,604 |
| Baxter Healthcare | 3 | $7,073 |
| Amgen | 11 | $569 |
| Aurinia Pharma U.S., Inc. | 8 | $133 |
| Boehringer Ingelheim | 5 | $92 |
| Boston Scientific | 1 | $64 |
| Fresenius USA Marketing, Inc. | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Seagen Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| GSK | 2 | $27 |
| Rockwell Medical, Inc. | 2 | $27 |
| Johnson & Johnson(2 entities) | 2 | $27 |
| Sanofi | 1 | $24 |
| Exelixis Inc. | 1 | $21 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Novartis | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Novo Nordisk | 1 | $16 |
| AbbVie | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Nxstage Medical, Inc. | 1 | $13 |
How this compares
$771,994 in reported general payments places this provider in the 95th percentile of 60 nephrology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Lincoln
- Michael AaronsonLincoln$498K
- Rachel BrockLincoln$87K
- Stephanie GawelLincoln$5K
- Matthew GlatharLincoln$1K
- Yifei ZhangLincoln$946
- Elizabeth CarthelLincoln$787
- Lisa ClevelandLincoln$758
- Son TranLincoln$468
- Sophia KnoellLincoln$390
- Nasimul GhaniLincoln$150
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.